The next steps for connected drug delivery
Pharma Technology Focus
Pharma Technology Focus brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insider views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry.
With healthcare systems further overburdened due the pandemic, it has never been so critical to improve patient adherence to drug treatments.
In the US, up to 50% of patients with chronic conditions fail to take their medications as prescribed, while in the UK, it is thought that between a third and a half of all medicines prescribed for long‑term conditions are not taken as recommended, increasing the risk of avoidable hospitalisation and escalating treatment costs in the long-term.
Digital tools are already playing a part in monitoring and improving adherence, especially for chronic respiratory conditions and for diabetes, but there remains wide scope for increased connectivity and remote patient monitoring.
In this article, George I’ons, Head of Product Strategy and Insights talks us through the next steps for connected drug delivery.